Source: eNeuro. Unidades: FMRP, EERP, FCF
Subjects: INFÂNCIA, DEPRESSÃO, FARMACOTERAPIA, SISTEMA HIPOTÁLAMO-HIPOFISÁRIO, ESTRESSE PSICOLÓGICO
ABNT
BARROCA, Nayara Cobra Barreiro et al. Evaluation of the HPA axis’ response to pharmacological challenges in experimental and clinical early-life stress-associated depression. eNeuro, v. 8, n. 1, p. 1-14, 2021Tradução . . Disponível em: https://doi.org/10.1523/ENEURO.0222-20.2020. Acesso em: 11 dez. 2024.APA
Barroca, N. C. B., Baes, C. V. W., Monteverde, C. M. S. M., Bosaipo, N. B., Umeoka, M. S. da S., Tejada, J., et al. (2021). Evaluation of the HPA axis’ response to pharmacological challenges in experimental and clinical early-life stress-associated depression. eNeuro, 8( 1), 1-14. doi:10.1523/ENEURO.0222-20.2020NLM
Barroca NCB, Baes CVW, Monteverde CMSM, Bosaipo NB, Umeoka MS da S, Tejada J, Antunes-Rodrigues J, Castro M de, Juruena MF, Garcia-Cairasco N, Umeoka EH de L. Evaluation of the HPA axis’ response to pharmacological challenges in experimental and clinical early-life stress-associated depression [Internet]. eNeuro. 2021 ; 8( 1): 1-14.[citado 2024 dez. 11 ] Available from: https://doi.org/10.1523/ENEURO.0222-20.2020Vancouver
Barroca NCB, Baes CVW, Monteverde CMSM, Bosaipo NB, Umeoka MS da S, Tejada J, Antunes-Rodrigues J, Castro M de, Juruena MF, Garcia-Cairasco N, Umeoka EH de L. Evaluation of the HPA axis’ response to pharmacological challenges in experimental and clinical early-life stress-associated depression [Internet]. eNeuro. 2021 ; 8( 1): 1-14.[citado 2024 dez. 11 ] Available from: https://doi.org/10.1523/ENEURO.0222-20.2020